CCS 2025: Getting to know the refractive surgery patient population

News
Video

Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.

In a Collaborative Care Symposium (CCS) 2025 presentation titled "Refractive Lens Exchange and Refractive Cataract Surgery," Mitch Ibach, OD, FAAO, spoke alongside Dagny Zhu, MD, discussing lens-based refractive surgical options for patients, particularly focusing on addressing vision correction needs in an aging population. In an interview with Optometry Times, Ibach highlighted several key considerations in modern vision correction strategies, including patient demographics and motivations and surgical approach, among others.

Ibach highlighted that the refractive surgery patient population consists of an aging US population seeking independence from glasses and contacts; patients who are interested in refractive surgery, but often at a life stage where corneal procedures might not be optimal; and patients with a desire to reduce dependence on corrective eyewear.

The 2 surgical approaches that are centered in the presentation include visually significant cataract surgery (partially covered by insurance) and refractive lens exchange (typically paid out-of-pocket). Both approaches aim to meet patient refractive goals, whether targeting solely distance vision with reading glasses or multiple focus points, such as distance, intermediate, and close-up.

Some critical referral and patient selection considerations include:

  • Importance of detailed referral notes from long-term care providers
  • Understanding patient personality and psychological readiness
  • Previous experiences with mono vision in contacts can be predictive
  • Hyperopic patients tend to adapt more easily to advanced lens technologies

As for patient expectation management, Ibach introduced the "Rule of 95", which refers to approximately 95% independence from glasses for most activities. The realistic expectation to set for patients is that some minor corrective wear might still be necessary. A red flag for Ibach to indicate that a patient may not be the best candidate for refractive surgery is those who claim they "never want to wear glasses again."

Additionally, technological advancements for patients include specialized, customizable lens technologies, the ability to match specific technologies to individual patient needs, and tailoring surgical approach based on the patient's unique characteristics.

Ibach's key takeaway from the presentation is that modern lens-based surgical options provide sophisticated, personalized vision correction strategies that can significantly reduce dependence on corrective eyewear while maintaining realistic patient expectations.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
Steven Greenstein, MD, one of the cochairs of the Collaborative Care Symposium gave some insight into the upcoming conference and what attendees can expect.
Dr Julie Poteet reports on patient-reported outcomes using lipid-containing artificial tear
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Karl Stonecipher ASCRS 2025
© 2025 MJH Life Sciences

All rights reserved.